Philippines Health News API

{
    "totalArticles": 98468,
    "articles": [
        {
            "id": "18c94b79563f47c6c77587ff18bc9a4e",
            "title": "POP Biotechnologies Secures Up to $9.7 Million in CEPI Funding",
            "description": "Funding to Propel POP BIO SNAP™ Nanoparticle Vaccine Platform into Phase 1 Clinical Trials in the U.S.",
            "content": "Funding to Propel POP BIO SNAP™ Nanoparticle Vaccine Platform into Phase 1 Clinical Trials in the U.S.\nBuffalo, NY, June 03, 2026 (GLOBE NEWSWIRE) -- POP Biotechnologies, Inc. (\"POP BIO”), a Buffalo-based biotechnology company developing next-generat... [7135 chars]",
            "url": "https://www.manilatimes.net/2026/06/04/tmt-newswire/globenewswire/pop-biotechnologies-secures-up-to-97-million-in-cepi-funding/2358359",
            "image": "https://www.manilatimes.net/manilatimes/uploads/images/2026/06/04/1084840.png",
            "publishedAt": "2026-06-03T23:43:56Z",
            "lang": "en",
            "source": {
                "id": "e3ad8bbf7dbe3c3defc56a8393455066",
                "name": "The Manila Times",
                "url": "https://www.manilatimes.net"
            }
        },
        {
            "id": "ea4967022efb0d4ede65d7ee4fcf1c84",
            "title": "ACTG Launches HIV Cure Study Evaluating Novel Approach Targeting the HIV Reservoir",
            "description": "CHAPEL HILL, N.C., June 03, 2026 (GLOBE NEWSWIRE) -- ACTG, a global clinical trials network focused on HIV and other infectious diseases, today announced the recent opening of study A5413, a study that expands upon the network’s commitment to finding a cure for HIV by looking at the HIV reservoir in people living with HIV who are on antiretroviral therapy (ART). A5413 is a randomized, double-blind, placebo-controlled clinical trial evaluating the safety, tolerability, and impact on the HIV reservoir of oral dasatinib among people living with HIV whose viral load is controlled by taking ART.",
            "content": "CHAPEL HILL, N.C., June 03, 2026 (GLOBE NEWSWIRE) -- ACTG, a global clinical trials network focused on HIV and other infectious diseases, today announced the recent opening of study A5413, a study that expands upon the network’s commitment to finding... [4501 chars]",
            "url": "https://www.manilatimes.net/2026/06/04/tmt-newswire/globenewswire/actg-launches-hiv-cure-study-evaluating-novel-approach-targeting-the-hiv-reservoir/2358356",
            "image": "https://www.manilatimes.net/manilatimes/uploads/images/2026/06/04/1084837.png",
            "publishedAt": "2026-06-03T23:03:47Z",
            "lang": "en",
            "source": {
                "id": "e3ad8bbf7dbe3c3defc56a8393455066",
                "name": "The Manila Times",
                "url": "https://www.manilatimes.net"
            }
        },
        {
            "id": "d3551c09a936158c325cd365d1d26300",
            "title": "New guidance on 'artificial pancreas' technology for pregnant women with type 1 diabetes",
            "description": "Women with type 1 diabetes who are pregnant or planning a pregnancy should be offered a pregnancy-specific 'artificial pancreas' device. That is the recommendation in draft guidance published tod",
            "content": "Women with type 1 diabetes who are pregnant or planning a pregnancy should be offered a pregnancy-specific 'artificial pancreas' device. That is the recommendation in draft guidance published today by NICE.\nThe device, known as a hybrid closed loop (... [6889 chars]",
            "url": "https://www.wired-gov.net/wg/news.nsf/articles/New+guidance+on+artificial+pancreas+technology+for+pregnant+women+with+type+1+diabetes+03062026141000?open",
            "image": "https://www.wired-gov.net/wg/news.nsf/channel-social/WGOV-9FZM3P/$file/xpc_social.gif",
            "publishedAt": "2026-06-03T13:14:08Z",
            "lang": "en",
            "source": {
                "id": "fc647bf0fa6c5217d1638857313909ef",
                "name": "Wired-GOV",
                "url": "https://www.wired-gov.net"
            }
        }
    ]
}